NILO Therapeutics
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $101M
Investors
- 5
About NILO Therapeutics
Nilo Therapeutics specializes in the development of therapies that target neural circuits to address autoimmune and inflammatory diseases.Nilo Therapeutics is focused on pioneering innovative immunomodulation therapies that leverage neural circuits to restore immune homeostasis in various autoimmune and inflammatory diseases. The company's core offerings center around targeting master regulatory brain-body circuits that play a critical role in managing systemic inflammation. This differentiated approach aims to address a broad range of conditions with significant unmet medical needs, thereby providing potential relief to patients suffering from these diseases.Nilo Therapeutics operates a revenue model primarily based on partnerships and collaborations with healthcare providers and research institutions, which facilitates the integration of their therapies into clinical settings. Transactions occur through direct agreements with hospitals and clinics, enabling them to access Nilo's products for their patient populations. The company plans to design and launch new products that target systemic inflammation and aims to expand into new markets, particularly in Europe and North America, by the end of 2026.
Who invested in NILO Therapeutics
5 investors across 1 round
See all investors in NILO Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 8, 2025
Amount
$101M
Investors
Questions about NILO Therapeutics
Who invested in NILO Therapeutics?
NILO Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NILO Therapeutics raised?
NILO Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NILO Therapeutics last raise money?
NILO Therapeutics's most recent round on record is a Series A, in Oct 2025.
What does NILO Therapeutics do?
Nilo Therapeutics specializes in the development of therapies that target neural circuits to address autoimmune and inflammatory diseases.
Where is NILO Therapeutics headquartered?
NILO Therapeutics is headquartered in New York, US.
Which VCs invest in companies like NILO Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NILO Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NILO Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.